MK0686 in Postsurgery Dental Pain (0686-002)

NCT ID: NCT00533403

Last Updated: 2015-06-26

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: PHASE2
• Total Enrollment: 114 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2004-07-31
• Study Completion Date: 2004-11-30

Brief Summary

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Conditions

Pain, Postoperative

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Interventions

MK0686

Intervention Type: DRUG

Eligibility Criteria

Inclusion Criteria

• Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
• Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria

• Patient has history of heart disease, asthma, pulmonary disease
• Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 45 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Medical Monitor

Role: STUDY_DIRECTOR

Merck Sharp & Dohme LLC

Other Identifiers

2007_617

Identifier Type: -

Identifier Source: secondary_id

0686-002

Identifier Type: -

Identifier Source: org_study_id